Testosterone Use in Menopausal Women; Public Workshop; Request for Comments
The Food and Drug Administration's (FDA) Office of Women's Health and the Center for Drug Evaluation and Research are announcing a public workshop titled "Testosterone Use in Menopausal Women." The purpose of the public workshop is to examine the current scientific evidence and critical knowledge gaps related to testosterone use in menopausal women to help inform future research and potential drug development of testosterone products for menopausal women. Researchers, educators, industry, clinicians, patients, and consumers may benefit from attending this scientific workshop. Presentations will examine the physiological roles of testosterone throughout a woman's life, including age-related decline, the menopausal transition, challenges associated with measuring and interpreting testosterone blood levels, and how these levels correlate with clinical symptoms and conditions. Speakers will review current and potential clinical uses of testosterone in menopausal women and examine the stren
Read the official notice →Source: Federal Register (FDA/USDA food labeling) · US Government work (public domain). This is a short, attributed summary; the full authoritative text lives on the authority’s own site. LabelYog does not author or endorse it — confirm compliance against the destination market’s official source.
More from United States
- Food Additives Permitted in Feed and Drinking Water of Animals; Chromium DL-methionine Chelate regulatory
- National Organic Program: Notice of Intent To Extend a Previously Approved Information Collection (Strengthening Organic Enforcement) (2026) regulatory
- Carboxin; Pesticide Tolerances regulatory
- Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I regulatory
- Schedules of Controlled Substances: Temporary Placement of 5,6-Dichloro Brorphine, 5,6-Dichloro Desmethylchlorphine, N-Propionitrile Chlorphine, and Spirochlorphine in Schedule I of the Controlled Substances Act regulatory
- Authorization of Emergency Use for Three Animal Drugs for the Prevention and Treatment of New World Screwworm; Availability regulatory
What this means for your label
A notice like this changes what a pack must carry. These are the rules we build against, starting with US FDA.